¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

´ëÇѾÆÅäÇÇÇǺο°ÇÐȸ IASS 2023 (Çмú´ëȸ) : 2023-05-10

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 

´ëÇѾÆÅäÇÇÇǺο°ÇÐȸ IASS 2023 (Çмú´ëȸ) : 2023-05-10
±³À°ÀÏÀÚ : 2023-05-10
±³À°Àå¼Ò : ±×·£µå ÀÎÅÍÄÁƼ³ÙÅ» ¼­¿ï Æĸ£³ª½º, ±×·£µåº¼·ë(5F)

±³À°ÁÖÁ¦ : IASS 2023 (Çмú´ëȸ)

ÁÖÃÖ±â°ü : ´ëÇÑÇǺΰúÇÐȸ
½ÃÇà±â°ü(ÁöºÎ/°ú) : ´ëÇѾÆÅäÇÇÇǺο°ÇÐȸ

´ã´çÀÚ : ÃÖ°æ¼ö
¿¬¶ôó : 02-2038-7674

À̸ÞÀÏ : IASS2022@humming.co.kr

±³À°Á¾·ù : ÇǺΰú

Âü¼®¿¹»óÀÎ : 300¸í
Èñ¸ÁÆòÁ¡ : 6Á¡

Áö¿ª : ¼­¿ïƯº°½Ã
±³À°½Ã°£ : 7 ½Ã°£ 0ºÐ

¼¼ºÎ¼ö°­·á : 500,000¿ø  

ºñ°í ÇǺΰú Àü¹®ÀÇ : 5¸¸¿ø·¹Áö´øÆ®, ¿¬±¸¿ø : 2¸¸¿øºñȸ¿ø : 50¸¸¿ø

±¸ºÐ ¿ùÀÏ °­ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ

±³À°½Ã°£ 05¿ù 10ÀÏ ±×·£µåº¼·ë 09:20~09:40 What¡¯s new in itch mechanism and therapeutic approaches for atopic dermatitis? Jiehyun Jeon(Korea Univ.)

±³À°½Ã°£ 05¿ù 10ÀÏ ±×·£µåº¼·ë 09:40~10:00 Characteristics for pediatric atopic dermatitis : What¡¯s the different  adult atopic dermatitis? Sang Eun Lee(Yonsei Univ.)

±³À°½Ã°£ 05¿ù 10ÀÏ ±×·£µåº¼·ë 10:00~10:20 Understanding of skin microbiome in atopic dermatitis for advance atopic dermatitis treatment Jihyun Lee(Catholic Univ.)

Åä·Ð 05¿ù 10ÀÏ ±×·£µåº¼·ë 10:20~10:30 Q&A ( )

±³À°½Ã°£ 05¿ù 10ÀÏ ±×·£µåº¼·ë 10:30~11:10 Introduction of the concept of minimal disease activity Mark Kirchhof(Ottawa Univ.)

Åä·Ð 05¿ù 10ÀÏ ±×·£µåº¼·ë 11:10~11:20 Q&A ( )

ÈÞ½Ä 05¿ù 10ÀÏ 11:20~11:35 Coffee Break ( )

±³À°½Ã°£ 05¿ù 10ÀÏ ±×·£µåº¼·ë 11:35~12:15 Can treatment impact the natural course of atopic dermatitis and comorbidity? Eric simpson(Oregon Health and Science Univ.)

Åä·Ð 05¿ù 10ÀÏ ±×·£µåº¼·ë 12:15~12:25 Q&A ( )

±³À°½Ã°£ 05¿ù 10ÀÏ ±×·£µåº¼·ë 12:25~12:45 Prominent role of type 2 inflammation in skin diseases: beyond atopic dermatitis (Jiyoung Ahn)

Åä·Ð 05¿ù 10ÀÏ ±×·£µåº¼·ë 12:45~12:55 Q&A ( )

½Ä»ç 05¿ù 10ÀÏ 12:55~13:20 Lunch ( )

±³À°½Ã°£ 05¿ù 10ÀÏ ±×·£µåº¼·ë 13:20~14:00 Current learning on the applications of atopic dermatitis therapy in real-world practice Stephan Weidinger(Christian-Albrechts Univ.)

Åä·Ð 05¿ù 10ÀÏ ±×·£µåº¼·ë 14:00~14:10 Q&A ( )

±³À°½Ã°£ 05¿ù 10ÀÏ ±×·£µåº¼·ë 14:10~14:50 How does baricitinib real-world evidence compare to randomized controlled trials? Andreas Wollenberg(Ludwig-Maximilian Univ.)

Åä·Ð 05¿ù 10ÀÏ ±×·£µåº¼·ë 14:50~15:00 Q&A ( )

ÈÞ½Ä 05¿ù 10ÀÏ ±×·£µåº¼·ë 15:00~15:15 Coffee Break ( )

±³À°½Ã°£ 05¿ù 10ÀÏ ±×·£µåº¼·ë 15:15~15:55 Long-term perspectives in atopic dermatitis Chih-Ho Hong(British Columbia Univ.)

Åä·Ð 05¿ù 10ÀÏ ±×·£µåº¼·ë 15:55~16:05 Q&A ( )

±³À°½Ã°£ 05¿ù 10ÀÏ ±×·£µåº¼·ë 16:05~16:25 Treat-to-target in atopic dermatitis : an important strategy for successful treatment Chan Ho Na(Chosun Univ.)

±³À°½Ã°£ 05¿ù 10ÀÏ ±×·£µåº¼·ë 16:25~16:45 Optimal use of JAK inhibitors for atopic dermatitis based on real-world experiences Min Kyung Shin(Kyung Hee Univ.)

±³À°½Ã°£ 05¿ù 10ÀÏ ±×·£µåº¼·ë 16:45~17:05 Update on the treatment of pediatric atopic dermatitis Jung-Im Na(Seoul National Univ.)

Åä·Ð 05¿ù 10ÀÏ ±×·£µåº¼·ë 17:05~17:15 Q&A ( )

 

ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" ´ëÇѾÆÅäÇÇÇǺο°ÇÐȸ IASS 2023 (Çмú´ëȸ) : 2023-05-10""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û ´ëÇѺñ´¢ÀÇÇÐȸ Á¦306ȸ Çмú´ëȸ(½ÅÀå¾Ï, ¹æ°ü¾Ï) : 2023-05-11
´ÙÀ½±Û ´ë»óÆ÷Áø ¹é½ÅÀÇ ÃÖ½ÅÁö°ß : 2023-05-10
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
20530 ¼­¿ï ¿¡ÀÌÄ¡Ç÷¯½º¾çÁöº´¿ø Á¦2024-1ȸ ¿¬¼ö°­Á : 2024-05-23 0 21 2024-04-29
20529 ¼­¿ï ´ëÇÑ»êºÎÀΰúÇÐȸ ¼­ºÎÁöȸ Á¤±â Áý´ãȸ : 2024-05-21 0 6 2024-04-29
20528 ¼­¿ï Á¾·Î±¸ÀÇ»çȸ ȸ¿ø¿¬¼ö±³À°(¾ß°£´¢, ´ç´¢Ä¡·á, ¹ß±âºÎÀü) : 2024-05-21 0 41 2024-04-29
20527 ¼­¿ï 2024 °­µ¿±¸ÀÇ»çȸ Á¦2Â÷ ¿¬¼ö±³À° : 2024-05-20 0 7 2024-04-29
20526 ¼­¿ï ¼Ò¾Æû¼Ò³âÇൿ¹ß´ÞÁõÁø ADHD ÇÁ·Î±×·¥ ¿öÅ©¼ó : 2024-05-19 0 18 2024-04-29
20525 ¼­¿ï ´ëÇѽÉÆóÇ÷°ü¸¶ÃëÇÐȸ 2024 KSCTVA Ãá°èÇмú´ëȸ(2ÀÏÂ÷) : 2024-05-19 0 23 2024-04-29
20524 ´ë±¸ ´ëÇѼҾÆû¼Ò³â°úÇÐȸ ´ë±¸¡¤°æºÏÁöȸ Ãá°èÇмú´ëȸ : 2024-05-19 0 17 2024-04-29
20523 ¼­¿ï 24³âµµ ´ëÇѱâ´ÉÀÇÇÐȸ Ãá°èÇмú´ëȸ : 2024-05-19 0 19 2024-04-29
20522 ¼­¿ï 2024³â ´ëÇѱÙÀüµµÀü±âÁø´ÜÀÇÇÐȸ Ãá°èÇмú´ëȸ : 2024-05-18 0 28 2024-04-29
20521 ¼­¿ï ´ëÇÑ°¡Á¤ÀÇÇÐȸ ¼­¿ïÁöȸ ¿¬¼ö°­Á : 2024-05-18 0 25 2024-04-29
20520 ¿ï»ê ¿ï»ê±¤¿ª½ÃÀÇ»çȸ Ç÷°üÀ» Á¶½ÉÇÏÀÚ : 2024-05-18 0 24 2024-04-29
20519 ¼­¿ï ´ëÇѽÉÆóÇ÷°ü¸¶ÃëÇÐȸ 2024 KSCTVA Ãá°èÇмú´ëȸ(1ÀÏÂ÷) : 2024-05-18 0 15 2024-04-29
20518 ¼­¿ï Áß¾Ó´ëÇб³º´¿ø ¾È°ú ½ÉÆ÷Áö¾ö : 2024-05-18 0 36 2024-04-29
20517 ¼­¿ï ´ëÇÑ·ù¸¶Æ¼½ºÇÐȸ 44th Korean College of Rheumatolgy Annual Scientific Meeting and the 18th International Symposium (KCR2024)-¼Â°³¯ : 2024-05-18 0 20 2024-04-29
20516 ¼­¿ï Á¦7ȸ °­ºÏ±¸ÀÇ»çȸ Çмú´ëȸ : 2024-05-18 0 31 2024-04-29
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷